Transmembrane proteins (TPs), also referred to as ‘integral membrane proteins’, make up between 70 % and 80 % of the total ...

This low-tech intervention could fundamentally shift how we treat cancer patients. It’s not every day that scientists uncover ...

In the battle against aggressive breast cancer, a once-elusive target is now within reach—thanks to a breakthrough from a ...

In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of ...

Oak Ridge researchers are converting nuclear waste into components for targeted alpha therapy, a cancer treatment that ...

The startup is using elements of gene and cell therapy to create medicines that could be useful against an array of tough-to-treat solid tumors.

Scientists have developed a hydrogel “rest stop” that shields cancer-fighting T cells, delaying their exhaustion and boosting ...

The "Ophthalmics Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of 344 ophthalmics ...

Thirty years ago a doctor named Mark Geier spread fears about vaccines and autism. Now his son, David, is reportedly looking ...